Get started
Author

Andrew Brohl

Observed name: Brohl, Andrew
Observed institution: Moffitt Cancer Center
OpenAlex ID: A5123252365
Drug-eluting bead transarterial chemoembolization treatment of liver-dominant metastatic leiomyosarcoma
2026 · Jonathan Henning, Shree Venkat, et al. · Abdominal Radiology
Additional file 10: Figure S7. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Additional file 4: Figure S2. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Additional file 11: Figure S8. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Additional file 7: Figure S4. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Additional file 14: Figure S10. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Additional file 8: Figure S5. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Additional file 3: Figure S1. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Additional file 9: Figure S6. of Development and clinical application of an integrative genomic approach to personalized cancer therapy
2016 · Uzilov, Andrew, Ding, Wei, et al. · Figshare
Works count: 17
Citation count:
H-index:
I10-index:
Year
Topic
Type